PMID- 32989960
OWN - NLM
STAT- MEDLINE
DCOM- 20210910
LR  - 20211207
IS  - 2724-5772 (Electronic)
IS  - 2724-5683 (Linking)
VI  - 69
IP  - 1
DP  - 2021 Feb
TI  - Factors associated with recurrent postinfarction ventricular tachycardia 
      following ablation.
PG  - 50-60
LID - 10.23736/S2724-5683.20.05128-2 [doi]
AB  - INTRODUCTION: Ablation of ventricular tachycardia is the main therapy for 
      patients with drug-refractory ventricular tachycardia (VT). Although evidence 
      suggests that VT ablation could lower the incidence of recurrent VT, many cases 
      still develop VT in follow-up. In this study, we performed a systematic review 
      and meta-analysis to examine risk factors for recurrent VT in patients with 
      postinfarction VT who underwent VT ablation. EVIDENCE ACQUISITION: We 
      comprehensively searched the databases of MEDLINE and EMBASE from inception to 
      March 2020. Included studies were cohort studies, experimental trials, or 
      randomized controlled trials that evaluate the risk of recurrent VT in 
      postinfarction VT patients who underwent VT ablation. Data from each study were 
      combined using random-effects. EVIDENCE SYNTHESIS: Thirteen studies involving 
      1803 postinfarction patients who underwent VT ablation were included. 
      Inducibility after the procedure (pooled HR=1.71, P<0.001), lower baseline left 
      ventricular ejection fraction (LVEF) (pooled HR=0.98, P<0.001) and higher 
      baseline New York Heart Association (NYHA) classification (pooled HR=1.34, 
      P=0.003) were significantly associated with VT recurrence during the follow-up. 
      There was no significant association between age, gender or diabetes mellitus and 
      VT recurrence. CONCLUSIONS: Our meta-analysis demonstrated that inducibility 
      after the procedure, lower baseline LVEF and higher baseline NYHA classification 
      were associated with an increased risk of VT recurrence in postinfarction VT 
      patients who underwent VT ablation.
FAU - Kewcharoen, Jakrin
AU  - Kewcharoen J
AD  - University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA - 
      jakrin@hawaii.edu.
FAU - Prasitlumkum, Narut
AU  - Prasitlumkum N
AD  - University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA.
FAU - Titichoatrattana, Sittinop
AU  - Titichoatrattana S
AD  - Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
FAU - Wittayalikit, Chutikarn
AU  - Wittayalikit C
AD  - Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
FAU - Trongtorsak, Angkawipa
AU  - Trongtorsak A
AD  - Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
FAU - Kanitsoraphan, Chanavuth
AU  - Kanitsoraphan C
AD  - University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA.
FAU - Putthapiban, Prapaipan
AU  - Putthapiban P
AD  - Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA.
FAU - Poonsombudlert, Kittika
AU  - Poonsombudlert K
AD  - University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA.
FAU - Rattanawong, Pattara
AU  - Rattanawong P
AD  - Department of Cardiovascular Diseases, Mayo Clinic, Phoenix, AZ, USA.
AD  - Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
FAU - Chung, Eugene H
AU  - Chung EH
AD  - Department of Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, 
      USA.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Systematic Review
DEP - 20200929
PL  - Italy
TA  - Minerva Cardiol Angiol
JT  - Minerva cardiology and angiology
JID - 101776555
SB  - IM
MH  - *Catheter Ablation
MH  - Humans
MH  - Recurrence
MH  - Stroke Volume
MH  - *Tachycardia, Ventricular/surgery
MH  - Ventricular Function, Left
EDAT- 2020/09/30 06:00
MHDA- 2021/09/11 06:00
CRDT- 2020/09/29 05:49
PHST- 2020/09/30 06:00 [pubmed]
PHST- 2021/09/11 06:00 [medline]
PHST- 2020/09/29 05:49 [entrez]
AID - S0026-4725.20.05128-2 [pii]
AID - 10.23736/S2724-5683.20.05128-2 [doi]
PST - ppublish
SO  - Minerva Cardiol Angiol. 2021 Feb;69(1):50-60. doi: 
      10.23736/S2724-5683.20.05128-2. Epub 2020 Sep 29.